| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/1997 | WO1997034871A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 09/25/1997 | WO1997034856A1 Novel pyruvate compounds and methods for use thereof |
| 09/25/1997 | WO1997034644A1 Topical formulations for the treatment of nail psoriasis |
| 09/25/1997 | WO1997034639A1 Animal model for transplantation |
| 09/25/1997 | WO1997034636A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/25/1997 | WO1997034635A1 Anti-idiotypic antibody vaccines |
| 09/25/1997 | WO1997034632A1 Glycosylated humanized b-cell specific antibodies |
| 09/25/1997 | WO1997034631A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | WO1997034629A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | WO1997034627A2 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 09/25/1997 | WO1997034626A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
| 09/25/1997 | WO1997034624A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | WO1997034623A1 Solid phase lipoglycopeptide library, compositions and methods |
| 09/25/1997 | WO1997034622A1 Oral cyclosporin formulations |
| 09/25/1997 | WO1997034618A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 09/25/1997 | WO1997034615A1 Enhancement of microbial colonisation of the gastrointestinal tract |
| 09/25/1997 | WO1997034612A1 Bis-anthracyclines with high activity against doxorubicin resistant tumors |
| 09/25/1997 | WO1997034611A1 Novel cystic fibrosis treatment |
| 09/25/1997 | WO1997034610A1 Process for producing efonidipine hydrochloride preparations |
| 09/25/1997 | WO1997034609A1 Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors |
| 09/25/1997 | WO1997034608A1 Combinations of an ursodeoxycholic acid compound and a nsaid for the chemopreventive protection of the colorectum |
| 09/25/1997 | WO1997034606A1 Uveitis remedy |
| 09/25/1997 | WO1997034605A1 Use of nicotine to treat liver disease |
| 09/25/1997 | WO1997034603A1 USE OF (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL IN TREATING DEPRESSIVE DISORDERS AND BIPOLAR DISORDERS |
| 09/25/1997 | WO1997034602A1 Paroxetine in treatment of depression |
| 09/25/1997 | WO1997034601A1 Drug compositions improved in solubility |
| 09/25/1997 | WO1997034600A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 09/25/1997 | WO1997034599A2 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 09/25/1997 | WO1997034598A1 Method of treating cancer using c-26 modified bryostatin |
| 09/25/1997 | WO1997034597A1 Use of antiarrhythmic compounds for reducing post-infarction mortality |
| 09/25/1997 | WO1997034596A1 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases |
| 09/25/1997 | WO1997034595A1 Method of treating neoplastic cells with prostaglandin |
| 09/25/1997 | WO1997034594A2 Use of allosteric haemoglobin modifier for treating solid tumors and inhibiting tumor metastases |
| 09/25/1997 | WO1997034593A1 AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES |
| 09/25/1997 | WO1997034592A1 Selection and/or enhancement of resident microorganisms in the gastrointestinal tract |
| 09/25/1997 | WO1997034591A1 Alteration of microbial populations in the gastrointestinal tract |
| 09/25/1997 | WO1997034590A1 New use of ammonium compounds and/or urea |
| 09/25/1997 | WO1997034589A1 Triaryl methane compounds for sickle cell disease |
| 09/25/1997 | WO1997034588A1 Propofol microdroplet formulations |
| 09/25/1997 | WO1997034587A2 Transdermal device |
| 09/25/1997 | WO1997034586A2 Device and method for treating ophthalmic diseases |
| 09/25/1997 | WO1997034584A1 Composite gel microparticles as active principle carriers |
| 09/25/1997 | WO1997034581A1 Method for solubilising hydrophylic materials (e.g. proteins) in a hydrophobic solvent |
| 09/25/1997 | WO1997034569A2 Pyronin antibacterials, process and intermediates |
| 09/25/1997 | WO1997034568A2 Antipsoriatic compositions, method of making, and method of using |
| 09/25/1997 | WO1997034566A2 Electrophilic ketones for the treatment of herpesvirus infections |
| 09/25/1997 | WO1997034565A2 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same |
| 09/25/1997 | WO1997034489A1 Antibacterially active marine algae extracts from the class diatomatae and methods of use |
| 09/25/1997 | WO1997034482A1 Xanthone analogs for the treatment of infectious diseases |
| 09/25/1997 | WO1997034472A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | WO1997031116A3 Recombinant ribonuclease proteins |
| 09/25/1997 | WO1997030704A3 Use of carbonic anhydrase inhibitors for treating macular edema |
| 09/25/1997 | WO1997030082A3 Antifungic and antibacterial peptide |
| 09/25/1997 | WO1997029778A3 Bioresponsive pharmacologically-active polymers and articles made therefrom |
| 09/25/1997 | WO1997027220A3 Substrates and inhibitors for cysteine protease ich-1 |
| 09/25/1997 | WO1997026968A3 Therapeutic anti-asthma agents containing selenium compounds |
| 09/25/1997 | WO1997026867A3 Solid instant-release forms of administration and process for producing the same |
| 09/25/1997 | WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/25/1997 | DE19628514C1 Synergistic inhibitor of HIV replication |
| 09/25/1997 | DE19610955A1 Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid Combination preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl) - anilide and N- (4-trifluoromethylphenyl) -2-cyano-3- hydroxycrotonamide |
| 09/25/1997 | DE19610882A1 Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 1,3,5-tri-substituted indazole derivatives having anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect, processes for their preparation and their use as medicaments |
| 09/25/1997 | CA2250320A1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 09/25/1997 | CA2250222A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | CA2250068A1 Electrophilic ketones for the treatment of herpesvirus infections |
| 09/25/1997 | CA2250016A1 Piperidine derivatives |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249994A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | CA2249739A1 Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use |
| 09/25/1997 | CA2249704A1 New use of ammonium compounds and/or urea |
| 09/25/1997 | CA2249593A1 Bis-anthracyclines with high activity against doxorubicin resistant tumors |
| 09/25/1997 | CA2249585A1 Animal model for transplantation |
| 09/25/1997 | CA2249571A1 Antibacterially active marine algae extracts from the class diatomatae and methods of use |
| 09/25/1997 | CA2249555A1 Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 09/25/1997 | CA2249551A1 A kinase capable of site-specific phosphorylation of i.kappa.b.alpha. |
| 09/25/1997 | CA2249481A1 Use of antiarrhythmic compounds for reducing post-infarction mortality |
| 09/25/1997 | CA2249471A1 Tricyclic compounds having activity specific for integrins, particularly .alpha.v.beta.3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same |
| 09/25/1997 | CA2249465A1 Purification of pharmaceutical-grade plasmid dna |
| 09/25/1997 | CA2249437A1 Novel pyruvate compounds and methods for use thereof |
| 09/25/1997 | CA2249420A1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
| 09/25/1997 | CA2249412A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | CA2249401A1 Novel asymmetric synthesis of r-.alpha.-propyl-piperonyl amine and its analogs |
| 09/25/1997 | CA2249368A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 09/25/1997 | CA2249323A1 Solid phase lipoglycopeptide library, compositions and methods |
| 09/25/1997 | CA2249274A1 Composite gel microparticles as active principle carriers |
| 09/25/1997 | CA2249247A1 Pyronin antibacterials, process and novel intermediates thereto |
| 09/25/1997 | CA2249196A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | CA2249195A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | CA2249189A1 Alteration of microbial populations in the gastrointestinal tract |
| 09/25/1997 | CA2249179A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | CA2249010A1 Xanthone analogs for the treatment of infectious diseases |
| 09/25/1997 | CA2248977A1 Topical formulations for the treatment of nail psoriasis |
| 09/25/1997 | CA2248879A1 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases |
| 09/25/1997 | CA2248868A1 Apoptosis inducing molecule ii |
| 09/25/1997 | CA2248843A1 Process for extraction of a growth factor complex |
| 09/25/1997 | CA2248629A1 Enzymes combinations for destroying proliferative cells |
| 09/25/1997 | CA2248614A1 Human cell death-associated protein |
| 09/25/1997 | CA2248573A1 Transdermal device |
| 09/25/1997 | CA2248351A1 Method for solubilising hydrophylic materials (e.g. proteins) in a hydrophobic solvent |
| 09/25/1997 | CA2248153A1 Heterocyclic compounds and their preparation and use |
| 09/25/1997 | CA2248092A1 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same |